Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate antigen: a marker for human prostate epithelial cells.

L D Papsidero, M Kuriyama, M C Wang

    Journal of the National Cancer Institute
    |January 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli.

    Journal of general microbiology·1992
    Same author

    Revision in American Cancer Society recommendations for the early detection of colorectal cancer.

    CA: a cancer journal for clinicians·1992
    Same author

    The association of benign prostatic hyperplasia and cancer of the prostate.

    Cancer·1992
    Same author

    Relapsing disease.

    Cancer·1992
    Same author

    The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Findings of the American Cancer Society National Prostate Cancer Detection Project.

    Cancer·1992
    Same author

    Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project.

    Cancer·1992
    Same journal

    Stat Bite: Time trends in lung cancer mortality in four European countries by sex, all ages combined, 1951-2022.

    Journal of the National Cancer Institute·2026
    Same journal

    Racial and ethnic disparities in clinical outcomes of HER2-positive metastatic breast cancer treated with antibody-drug conjugates.

    Journal of the National Cancer Institute·2026
    Same journal

    Breast cancer risk prediction with artificial intelligence: promise, calibration, and clinical readiness.

    Journal of the National Cancer Institute·2026
    Same journal

    RE：Electroacupuncture improves cognitive function and neuropsychiatric symptoms in breast cancer survivors: a pilot randomized controlled trial.

    Journal of the National Cancer Institute·2026
    Same journal

    Worsening frailty and declining quality of life in older survivors of non-metastatic breast cancer.

    Journal of the National Cancer Institute·2026
    Same journal

    Longitudinal effects of comorbidities on brain structure and cognition in older breast cancer survivors.

    Journal of the National Cancer Institute·2026
    See all related articles

    This study confirms a prostate antigen (PA) is specific to prostate ductal epithelial cells. Malignant prostate cell lines express and release this antigen, indicating its potential as a prostate cancer biomarker.

    Area of Science:

    • Urology
    • Immunology
    • Cancer Biology

    Background:

    • A previously reported prostate antigen (PA) expression was investigated.
    • Understanding the localization and release of PA is crucial for biomarker development.

    Purpose of the Study:

    • To assess the specificity of a known prostate antigen (PA).
    • To determine the expression and release of PA by prostate cancer cell lines.
    • To evaluate PA's potential as a biomarker for prostate cancer.

    Main Methods:

    • Immunologic procedures were employed to assess antigen specificity.
    • Prostate cancer cell lines (LNCaP and PC-3) were used for expression studies.
    • In vitro and in vivo models were utilized to study antigen release.

    Related Experiment Videos

    Main Results:

    • The prostate antigen (PA) was found to be specifically located within ductal epithelial cells of the prostate gland.
    • Both LNCaP and PC-3 malignant prostate cell lines demonstrated sustained expression of PA.
    • Tumor cells were observed to release PA in vitro into culture media and in vivo into the bloodstream of nude mice.
    • Prostate cells in culture specifically bound immunoglobulin fragments from PA antiserum.

    Conclusions:

    • The prostate antigen (PA) exhibits high specificity for prostate ductal epithelial cells.
    • PA is expressed and released by malignant prostate cell lines, suggesting its potential utility.
    • Further research into PA as a diagnostic or prognostic biomarker for prostate cancer is warranted.